Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 2443-2447, December 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. H.
Right arrow Articles by Djordjevic, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. H.
Right arrow Articles by Djordjevic, B.

Studies on Unbalanced Growth in Synchronized HeLa Cells1

Jae Ho Kim, Amaury G. Perez and Bozidar Djordjevic

Division of Biophysics, Sloan-Kettering Institute for Cancer Research, and Cornell University Graduate School of Medical Sciences, Cornell University Medical College, New York, New York 10021

Unbalanced growth leading to a loss of colony-forming ability is induced by exposing mitotically synchronized HeLa cells to inhibitors of DNA synthesis. A sharply reduced cell survival (colony-forming ability) is observed following exposure of cells in the G1-S transition phase to 1-ß-D-arabinofuranosylcytosine or hydroxyurea for a period longer than 6–8 hr, a period corresponding to about the duration of the DNA synthetic phase (S) in HeLa cells. A decrease in cell survival occurs when the cells in mitosis are exposed to the inhibitors of DNA synthesis for a period longer than 16 hr, a period corresponding to about the duration of the G1 and the S phases. Thus, it is concluded that the minimum time period needed for the induction of unbalanced growth leading to a loss of cell viability following exposure of HeLa cells to an inhibitor of DNA synthesis would be equal to the duration of DNA synthesis.

The use of cycloheximide, an inhibitor of protein synthesis, reverses the lethal effect of the inhibition of DNA synthesis. This finding indicates that the synthesis of protein may be one of the requisite steps in the induction of the unbalanced growth syndrome.

1 This work was aided by grants from the National Cancer Institute (CA 08748) and the Atomic Energy Commission (AT (30-1)-910).

Received 5/23/68. Accepted 8/26/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.